Antonella De Luca

1 article listing Antonella De Luca in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. First-line Nivolumab plus FOLFOXIRI/Bevacizumab in advanced RAS/BRAF-mutated colorectal cancer: efficacy, safety and biomarker discovery from the phase II NIVACOR trial Nature Communications